Home › Funds › BNP Paribas Asset Management Holding S.A. › GILD

BNP Paribas Asset Management Holding S.A. position in GILD

GILEAD SCIENCES INC · Health Care

BNP Paribas Asset Management Holding S.A. reported holding 4,627,685 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$689.8M, representing 0.69% of its reported portfolio and ranking #21 among its reported holdings. BNP Paribas Asset Management Holding S.A. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.63M sh
Reported value held$689.78M
Portfolio Weight0.69%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BNP Paribas Asset Management Holding S.A.'s GILD position evolved

BNP Paribas Asset Management Holding S.A. first disclosed a stake in GILD in Q3 2023 at 979,121 shares (US$73.4M). The position peaked in Q3 2026 at 4,627,685 shares, worth US$689.8M. Across 13 filings, BNP Paribas Asset Management Holding S.A. increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,627,685 shares valued at US$689.8M — an increase of 688,911 shares quarter over quarter.. Notable position changes include a 137% increase in Q4 2024 (shares rose 21% over the following quarter), a 52% increase in Q1 2025 (shares were roughly flat over the following quarter), a 117% increase in Q4 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 979.12K $73.38M New
Q4 2023 1.36M $110.47M Add
Q1 2024 666.34K $48.81M Reduce
Q2 2024 553.03K $37.94M Reduce
Q3 2024 764.52K $64.10M Add
Q4 2024 1.81M $167.34M Add
Q1 2025 2.75M $308.41M Add
Q2 2025 2.40M $265.85M Reduce
Q3 2025 1.69M $186.83M Reduce
Q4 2025 3.67M $450.77M Add
Q1 2026 4.42M $616.34M Add
Q2 2026 3.94M $497.62M Reduce
Q3 2026 4.63M $689.78M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has BNP Paribas Asset Management Holding S.A. held GILD?

BNP Paribas Asset Management Holding S.A. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BNP Paribas Asset Management Holding S.A.'s current position in GILD?

As of Q3 2026, BNP Paribas Asset Management Holding S.A. holds 4.63M shares of GILD (GILEAD SCIENCES INC), valued at $689.78M, representing 0.69% of its reported portfolio and ranking #21.

Has BNP Paribas Asset Management Holding S.A. been buying or selling GILD?

In the latest 13F filing (Q3 2026), BNP Paribas Asset Management Holding S.A. increased its position in GILD. The position peaked in Q3 2026 at 4.63M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.